会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 3-Nitropyrazole compounds and anti-microbial compositions
    • 3-硝基吡唑化合物和抗微生物组合物
    • US4172136A
    • 1979-10-23
    • US889594
    • 1978-03-23
    • Herbert BergerRudi GallKurt Stach, deceasedMax ThielWolfgang Vomel
    • Herbert BergerRudi GallKurt Stach, deceasedMax ThielWolfgang Vomel
    • C07D231/16C07D401/02C07D403/02
    • C07D231/16
    • New 3-nitropyrazole compounds of the formula: ##STR1## wherein R.sub.1 is lower alkyl;R.sub.2 is hydrogen or lower alkyl;R.sub.3 is cyano, carboxyl or lower alkoxycarbonyl or the radical --CO-NR.sub.4 R.sub.5, in whichR.sub.4 is hydrogen or hydroxyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, thiocarbamoyl, ureido, thioureido, hydroxyphenyl, picolyl or is a lower alkyl, alkenyl or cycloalkyl radical substituted, if desired, by a cyano, hydroxyl, pyrrolidino, piperidino, amino, lower alkylamino, lower dialkylamino or lower acylamino substituent andR.sub.5 is a hydrogen atom or a lower alkyl radical orR.sub.4 and R.sub.5 together represent a lower alkylene bridge;And the pharmacologically compatible salts thereof are outstandingly effective as anti-microbial agents, particularly systemically and in the urinary tract.
    • 新的具有下式的3-硝基吡唑化合物:其中R 1是低级烷基; R2是氢或低级烷基; R3是氰基,羧基或低级烷氧基羰基或基团-CO-NR4R5,其中R4是氢或羟基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,硫代氨基甲酰基,脲基,硫脲基,羟基苯基,吡啶甲基或是低级烷基,烯基或环烷基取代 如果需要,通过氰基,羟基,吡咯烷子基,哌啶子基,氨基,低级烷基氨基,低级二烷基氨基或低级酰基氨基取代基,R 5是氢原子或低级烷基,或者R 4和R 5一起代表低级亚烷基桥; 并且其药理学兼容的药物作为抗微生物药剂,特别是在系统性和在尿道感染中是非常有效的。
    • 7. 发明授权
    • Nitroimidazolyl-triazolo-pyridazine compounds
    • 硝基咪唑基 - 三唑并 - 哒嗪化合物
    • US4006141A
    • 1977-02-01
    • US601116
    • 1975-07-31
    • Herbert BergerRudi GallKurt StachWolfgang VomelRita Hoffmann
    • Herbert BergerRudi GallKurt StachWolfgang VomelRita Hoffmann
    • C07D487/04
    • C07D487/04
    • Nitroimidazolyl-s-triazolo[4,3-b]pyridazines of the formula: ##STR1## wherein R is hydrogen or lower alkyl optionally substituted in the 2-position by hydroxyl or by lower acyloxy or lower alkoxy;A is hydrogen, halogen, azido, cyano; lower alkyl alkoxy, alkylthio, alkylsulfonyl, carboxyl; lower alkoxycarbonyl, lower alkoxycarbonimidoyl; or hydrazino, carbamoyl, amidino or a carboximidohydrazide group optionally substituted by one or two lower acyl, alkyl or cycloalkyl radicals; orA is a radical of the formula: ##STR2## wherein R.sub.1 and R.sub.2 are, individually, hydrogen or a number of organic radicals or, taken together, can be an alkylene bridge; andR.sub.3 is hydrogen or lower alkyl; or, together with R.sub.2, R.sub.3 can form an alkylene bridge;n is 0 or 1;And the pharmaceutically compatible thereof, possess high in vivo effectiveness as antimicrobials.
    • 具有下式的硝基咪唑基-s-三唑并[4,3-b]哒嗪:其中R是氢或在2-位被羟基或低级酰氧基或低级烷氧基任选取代的低级烷基; A是氢,卤素,叠氮基,氰基; 低级烷基烷氧基,烷硫基,烷基磺酰基,羧基; 低级烷氧基羰基,低级烷氧羰基亚氨基; 或肼基,氨基甲酰基,脒基或任选被一个或两个低级酰基,烷基或环烷基取代的碳代酰肼基; 或者A是下式的基团:其中R 1和R 2分别是氢或多个有机基团,或者一起可以是亚烷基桥; 并且R 3是氢或低级烷基; 或者与R 2一起形成亚烷基桥; N IS 0或1; 并且与药物相容,作为抗病毒药物具有高度的生物有效性。